IGAN
Clinical trials for IGAN explained in plain language.
Never miss a new study
Get alerted when new IGAN trials appear
Sign up with your email to follow new studies for IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection trial aims to protect kidneys from immune attack
Disease control Recruiting nowThis study is testing an investigational drug called atacicept in people with several autoimmune kidney diseases. Participants will receive weekly injections to see if the treatment is safe and if it can reduce harmful protein in the urine and help preserve kidney function. The g…
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial offers hope for rare kidney disease patients
Disease control Recruiting nowThis study is testing an experimental drug called ADX-038 for adults with specific immune-related kidney diseases. Researchers want to see if the drug is safe and effective at controlling these conditions. The trial will enroll 45 participants who have been diagnosed with disease…
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial aims to protect Kids' kidneys from rare disease
Disease control Recruiting nowThis study is testing whether the drug ravulizumab can help children and teenagers (ages 2-18) with IgA nephropathy, a kidney disease where the immune system attacks the kidneys. Participants will receive the drug through an IV to see if it reduces protein in their urine and slow…
Matched conditions: IGAN
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Major trial tests new drug to protect kidneys from silent disease
Disease control Recruiting nowThis study is testing whether the drug ravulizumab can slow the progression of IgA nephropathy (IgAN), a kidney disease that can lead to kidney failure. About 510 adults with IgAN who are at high risk of their disease getting worse will receive either the study drug or a placebo …
Matched conditions: IGAN
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC